ABSTRACT
The revolution in nanotechnology has significantly benefited several scientific areas, including pharmaceuticals. The effectiveness of nanotechnology in healthcare has been explored in this chapter. The focus of the chapter includes, but is not limited to, nanomedicines available in the market, the concept of nanopharmaceuticals, and the associated techniques. The fast-track development in nanomaterial research has addressed the limitations of therapeutic and diagnostic agents of conventional medicines. The designing of different nano-carriers for modifying the half-life of compounds, altering the bio-distribution, and controlling the release of a drug will ultimately benefit patients. Many research studies have been conducted across various parts of the world to develop nanopharmaceuticals which would play a significant role in the healthcare system. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved about fifty (50) nanoformulations available in the market. However, several issues withhold these formulations from unlocking their translational perspectives. Our objective is to elucidate the importance of nanotechnology in developing nanopharmaceuticals, clinical success, and future clinical trends for various therapeutic purposes.
